This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Valeant Pharmaceuticals International, Inc.
Drug Names(s): IDP-123
Description: IDP-123 is a novel acne combination with an undisclosed mechanism of action.
Pink Sheet FDA Performance Tracker: User Fee Goal Dates
Additional information available to subscribers only: